dilution is always a painbut they are planning on a profit by the end of this financial year and that does not include any returns on the safety syringeprofits will have a huge impact when they come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025